Literature DB >> 27822730

Effects of an electronic reminder system on guideline-concordant treatment of psychotic disorders : Results from a pilot feasibility trial.

Irina Franke1, Sarah Thier2, Anita Riecher-Rössler3.   

Abstract

BACKGROUND: Adherence to evidence-based guidelines is essential for the treatment outcome of psychotic disorders. Previous studies showed that IT-supported pathways are able to increase guideline adherence in psychiatric care. This paper describes a pilot study on the development of an electronic recall-reminder-system (RRS) for supporting guideline-adherent treatment in outpatient care of patients with chronic psychotic disorders and analyses its feasibility.
METHODS: Guidelines were integrated in the RRS software M.E.M.O.R.E.S. Software training for the staff was provided. We compared the number of conducted vs. guideline-recommended interventions 6 months before and after implementation. Subsequently both the caregivers' and the patients' satisfaction with the RRS was evaluated.
RESULTS: Guideline adherence in general was low and the RRS was barely used. After its implementation a significant increase was observed in chemogram-check-ups and diagnostics regarding cardiovascular risks (esp. ECG). Both patients and professionals described problems with integrating the RRS in their daily routine and questioned the usefulness of the guidelines for chronically ill, although they basically approved its importance and usefulness.
CONCLUSIONS: Participants appreciated the idea of supporting guideline adherence with an IT-system, but there seemed to be major obstacles to implementation: caregivers appear to be concerned of being exposed or questioned, technical difficulties might lead to avoidance, and there seems to be a lack of knowledge and awareness about the health risks for individuals with psychotic disorders. Possibly guidelines adapted for the chronically ill would find more acceptance. Technical simplifications and better information should be considered prior to further attempts to implement IT-supported guidelines in order to increase acceptance.

Entities:  

Keywords:  Acceptance; Clinical guidelines; Guideline adherence; IT-pathway-systems; Psychotic disorders; Treatment

Mesh:

Substances:

Year:  2016        PMID: 27822730     DOI: 10.1007/s40211-016-0202-1

Source DB:  PubMed          Journal:  Neuropsychiatr        ISSN: 0948-6259


  30 in total

1.  A new scale (SES) to measure engagement with community mental health services.

Authors:  Lynda Tait; Max Birchwood; Peter Trower
Journal:  J Ment Health       Date:  2002

2.  Mortality in patients with schizophrenia.

Authors:  M De Hert; J Peuskens; R van Winkel
Journal:  Lancet       Date:  2009-11-07       Impact factor: 79.321

3.  Antipsychotics and mortality in first-onset schizophrenia: prospective Finnish register study with 5-year follow-up.

Authors:  Marjo Kiviniemi; Jaana Suvisaari; Heli Koivumaa-Honkanen; Unto Häkkinen; Matti Isohanni; Helinä Hakko
Journal:  Schizophr Res       Date:  2013-08-14       Impact factor: 4.939

4.  [Guideline compliance in the treatment of schizophrenic patients. Introduction of a computer-assisted treatment pathway].

Authors:  F Godemann; K Blittersdorf; M Poschenrieder; H Klimitz; I Hauth; H Gutzmann
Journal:  Nervenarzt       Date:  2010-05       Impact factor: 1.214

5.  [Guideline conformity and outcome of inpatient treatment for schizophrenia. A clinical comparison].

Authors:  B Janssen; S Weinmann; M Berger; M Härter; T Held; M Leipert; H J Luderer; M Schwarz; T Steinert; W Gaebel
Journal:  Nervenarzt       Date:  2005-03       Impact factor: 1.214

6.  Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis.

Authors:  Davy Vancampfort; Brendon Stubbs; Alex J Mitchell; Marc De Hert; Martien Wampers; Philip B Ward; Simon Rosenbaum; Christoph U Correll
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

Review 7.  The effectiveness of telemental health: a 2013 review.

Authors:  Donald M Hilty; Daphne C Ferrer; Michelle Burke Parish; Barb Johnston; Edward J Callahan; Peter M Yellowlees
Journal:  Telemed J E Health       Date:  2013-06       Impact factor: 3.536

8.  [The Basel Screening Instrument for Psychosis (BSIP): development, structure, reliability and validity].

Authors:  A Riecher-Rössler; J Aston; J Ventura; M Merlo; S Borgwardt; U Gschwandtner; R-D Stieglitz
Journal:  Fortschr Neurol Psychiatr       Date:  2008-04       Impact factor: 0.752

9.  Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006.

Authors:  Uy Hoang; Robert Stewart; Michael J Goldacre
Journal:  BMJ       Date:  2011-09-13

10.  Atypical antipsychotic drugs and the risk of sudden cardiac death.

Authors:  Wayne A Ray; Cecilia P Chung; Katherine T Murray; Kathi Hall; C Michael Stein
Journal:  N Engl J Med       Date:  2009-01-15       Impact factor: 176.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.